Novavax is up a bit on the day, funds flowing in kept the price up 1.76% since yesterday.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. But we can consider it's momentum, Novavax has seen a lot of selling over the last year which hasn't let up, this thing has really been sliding. People who bought the Biotechnology company have lost -92.61 percent over the last 12 months, not great! I would wait until it get to a better support level before rolling the dice on this one. NVAX might find some support at the 36.28 level, buyers might push the price back up from here. But it's not very clear what will happen.
Overall, the analysts have a more negative view on Novavax but it's not a very strong negative. The current Analysts Sentiment Score is -26.83. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2023-03-01 B. Riley downgraded Novavax from Buy to Neutral. On 2023-02-13 HC Wainwright reiterated their rating of Buy and added a price target of $110.00. Jefferies Financial Group initiated a rating of Hold on 2022-12-02. Cowen dropped their 1 year price target to 55.00 on 2022-10-13. JPMorgan Chase & Co. released a downgrade on 2022-09-22 from Neutral to Underweight and dropped their 1 year price target to $27.00 which is down from $132.00. Cantor Fitzgerald boosted their price targ by 15.07% to $168.00 on 2022-06-08. Bank of America announced that they are initiating coverage with a rating of Underperform on 2022-05-20 and added a price target of $35.00. On 2021-09-01 there was confirmation of the previous rating by Chardan Capital which was Neutral. On 2020-08-05 there was a downgrade announced by LADENBURG THALM/SH SH from Neutral to Sell and provided a price target of $105.00. Oppenheimer gave a boost to their price target and moved to $38.50 from $19.00 on 2020-05-12.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| NVAX | -26.83 | 66.89 | -96.71 | 2.64 | -26.48 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| NVAX | 24.14 | -22.81 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| NVAX | 19.45 | %32.3634 | 3.9 | 7.92 | 24470000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 367 | 1.65 | -1.04 | -10.59 | 1.90 | -6.98 | -22.13 | 31.57 | -13.77 | -17.27 | -13.81 | -41814.93 | -3164.24 | 0.95 | 21.19 | 6.54 | 48.84 |
| Healthcare | 617 | 1.67 | -0.48 | -8.71 | 1.89 | -6.28 | -24.08 | 31.85 | -11.33 | -14.45 | -14.07 | -36805.91 | -4054.41 | 1.05 | 22.33 | 5.93 | 36.37 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| NVAX | 2.00 |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. Com | 1.07 | -1.83 | -4.51 | -17.44 | -11.64 | -44.90 | -53.76 | 37 | -40.45 | -51.84 | -32.99 | -35323.24 | 0.00 | 0 | 0 | 23.6706 |
| MRNA | Moderna, Inc. Common Stoc | 1.05 | -0.98 | 2.27 | -3.27 | -26.56 | 17.96 | -12.76 | 58 | -8.57 | -5.63 | -3.76 | -18307.07 | -1604.80 | 0 | 0 | 4.13514 |
| ARCT | Arcturus Therapeutics Hol | 1 | 0.33 | -3.39 | -12.40 | -12.65 | 2.67 | -37.07 | 39 | -8.84 | -9.64 | -5.49 | -21561.62 | -997.14 | 0 | 0 | 7.769 |
| VXRT | Vaxart, Inc Common Stock | 0.92 | 2.89 | -3.96 | -20.23 | -18.54 | -68.40 | -85.40 | 40 | -124.67 | -92.44 | -107.36 | -109683.72 | 186.89 | 0 | 0 | 12.2998 |
| INO | Inovio Pharmaceuticals, I | 0.91 | -2.80 | -9.57 | -25.71 | -35.00 | -44.39 | -71.35 | 37 | -70.43 | -55.25 | -52.32 | -52109.50 | 0.00 | 0 | 0 | 14.7766 |
| BNTX | BioNTech SE American Depo | 0.91 | 0.95 | 2.61 | -0.97 | -25.88 | -0.10 | -21.63 | 45 | -25.12 | -11.21 | -24.00 | -32432.04 | -222.54 | 0 | 0 | 0.814301 |
| CVAC | CureVac N.V. Ordinary Sha | 0.84 | 1.02 | -1.00 | -20.80 | 6.13 | -23.00 | -64.50 | 29 | -15.86 | -35.70 | -22.78 | -69934.55 | -620.67 | 0 | 150 | 3.99811 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
